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R E S E A R C H  A R T I C L E
 Space sickness aff ects over 50% of astronauts in the fi rst 24 – 72 h in space.  1  An analysis of astronauts who fl ew in the Space Shuttle indicated that 67% had some symptoms 
and 13% experienced severe sickness.  4  Aft er this initial expo-
sure most astronauts adapt, although some re-emergence of 
symptoms may occur on return to the 1 g environment of 
Earth, a kind of mal-de-débarquement syndrome. Zero-G par-
abolic fl ight reproduces the weightlessness of space for short 
periods. It has proved an invaluable research tool. Th e time 
duration of exposure to an altered force environment in para-
bolic fl ight is much shorter than weightlessness in space. 
Despite this shorter exposure, motion sickness may be a signifi -
cant problem for some zero-G fl iers. 
 Several mechanisms have been proposed for space motion 
sickness and by extension for zero-G fl ight. Th e fl uid shift  
hypothesis for space motion sickness, i.e., the observed cephalic 
shift  of body fl uids to the head, is now largely discounted,  11 , 14  
although such eff ects may make astronauts look temporarily 
younger in the face, notwithstanding possible long-term dam-
aging eff ects on the ocular nerve. It is now generally accepted 
that the vestibular system is the key for all motion sickness, 
including space sickness. Th e otolith tilt translation hypothe-
sis  16  would suggest that movement of the head in weightlessness 
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 Prevalence, Predictors, and Prevention of Motion 
Sickness in Zero-G Parabolic Flights 
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  INTRODUCTION:  Zero-G parabolic fl ight reproduces the weightlessness of space for short periods. However, motion sickness may aff ect 
some fl iers. The aim was to assess the extent of this problem and to fi nd possible predictors and modifying factors. 
  METHODS:  Airbus zero-G fl ights consist of 31 parabolas performed in blocks. Each parabola consisted of 20 s of 0 g sandwiched by 
20 s of hypergravity of 1.5 – 1.8 g. The survey covered  N  5 246 person-fl ights (193 men, 53 women), ages (M  6 SD) 36.0  6 
11.3 yr. An anonymous questionnaire included motion sickness rating (1  5 OK to 6  5 vomiting), Motion Sickness 
Susceptibility Questionnaire (MSSQ), antimotion sickness medication, prior zero-G experience, anxiety level, and other 
characteristics. 
  RESULTS:  Participants had lower MSSQ percentile scores (27.4  6 28.0) than the population norm of 50. Motion sickness was 
experienced by 33% and 12% vomited. Less motion sickness was predicted by older age, greater prior zero-G fl ight 
experience, medication with scopolamine, lower MSSQ scores, but not gender or anxiety. Sickness ratings in fl iers 
pretreated with scopolamine (1.81  6 1.58) were lower than for nonmedicated fl iers (2.93  6 2.16), and incidence of 
vomiting in fl iers using scopolamine treatment was reduced by half to a third. Possible confounding factors including 
age, sex, fl ight experience, and MSSQ could not account for this. 
  CONCLUSION:  Motion sickness aff ected one-third of zero-G fl iers despite being intrinsically less motion sickness susceptible compared 
to the general population. Susceptible individuals probably try to avoid such a provocative environment. Risk factors for 
motion sickness included younger age and higher MSSQ scores. Protective factors included prior zero-G fl ight experi-
ence (habituation) and antimotion sickness medication. 
  KEYWORDS:  motion sickness ,  parabolic ,  space ,  vestibular ,  scopolamine ,  habituation ,  age . 
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will cause ambiguous interpretations of otolith output, since 
there can be no tilt and signals will be perceived as translation. 
Th us the inherent ambiguity of tilt vs. translation perception of 
otolith signals, normally resolved by the brain through the 
expectation of low vs. high motion frequencies in the terrestrial 
environment,  8  now becomes overwhelming since there is no 
background gravity vector. Moreover, the absence of the gravity 
vector will produce what is arguably an additional confl ict, that 
is between otolith and semicircular canal signals under condi-
tions of weightlessness.  1  It has also been suggested that any 
asymmetries between otoliths which have been compensated for 
by neural mechanisms at 1 g become unmasked under weight-
lessness, with a consequent mismatch between signals from 
otoliths in the left  and right labyrinths.  5  Another hypothesis is 
that, under weightlessness, the otolith hair cell cilia return to 
their neutral positions, which means that their combined sig-
nals will indicate simultaneous multiple possible directions of 
the gravity vector, producing continuous multiple confl icts.  21  
Th is is reminiscent of a violation of the third rule of the three 
general vestibular consistency rules proposed by Stott:  20   “ Utricle-
Saccule: any sustained linear acceleration is due to gravity, has 
an intensity of 1 g and defi nes  ‘ downwards ’. ” 
 However, unlike in the weightlessness of space, during zero-
G parabolic fl ight there is an additional provocative stimulus. 
Th e hypergravity periods during parabolic fl ight must also be 
considered. It has been shown that head movements even when 
performed only during the hypergravity portions of parabolic 
fl ight are suffi  cient to cause motion sickness.  12  Th is is also true 
of head movements during sustained hypergravity fl ight.  13  Th e 
latter avoids any confounding due to the nauseogenic eff ects of 
Coriolis cross-coupling if sustained hypergravity is induced by 
centrifuge rotation. Th e mechanism for this eff ect is doubtless a 
canal-otolith confl ict due to exposure to a nonterrestrial force 
background, but where excess rather than reduced otolith sig-
nals are the source of the confl ict. 
 Th is study had two main aims. Th e fi rst was to assess the 
current extent of the problem of motion sickness in Airbus 
zero-G parabolic fl ights using an anonymous survey to reduce 
reporting bias. Moreover, most previous studies on this topic 
have involved relatively small numbers of fl iers on parabolic 
fl ights and our target was to obtain both a large sample and high 
response rates to reduce sampling bias. Given a large sample, 
the second main aim was to fi nd individual motion sickness 




 Zero-G fl ier participants were healthy volunteers with healthy 
vestibular function and not on current medication. Th ey were 
fully briefed by an information sheet, gave informed consent, 
and were free to withdraw at any time. Ethical approval was 
granted by the Ethics Committee (Psychology) of the Univer-
sity of Westminster. 
 Questionnaire 
 Th e questionnaire was available in both English and French 
language versions. In order to encourage high participation 
rates, it was designed to be quick and easy to complete (4 min 
approximately). It comprised the following items: age and gen-
der demographics; current menstruation (women only); the 
maximum motion sickness rating experienced during the fl ight 
on a validated scale  2  (1  5 OK, 2  5 initial symptoms, 3  5 mild 
nausea, 4  5 moderate nausea, 5  5 severe nausea &/or retching, 
6  5 vomiting); approximate time of onset of sickness (at begin-
ning, middle, or end of the 31-parabola series); use of antimo-
tion sickness medication (yes/no); write-in box for the name of 
any drug with example prompts such as  ‘ scopolamine, scopdex, 
Stugeron, etc. ’ ; prior zero-G experience (number of fl ights); 
anxiety level during the fl ight on a 5-point scale (0  5 none, 1  5 
mild, 2  5 moderate, 3  5 high, 4  5 extreme); when the ques-
tionnaire was completed (immediately,  , 1 h, 1 – 3 h,  . 3 h, 
following day aft er the fl ight); and the short-form Motion Sick-
ness Susceptibility Questionnaire (MSSQ). Th e MSSQ is a vali-
dated questionnaire that reliably predicts motion sickness 
tolerance from testing in laboratory settings and from vehicular 
motion  7  and is also validated for the French language.  15  Th e 
MSSQ is divided into two parts: Part A (MSA) refers to the 
experience of motion sickness in childhood; Part B (MSB) 
concerns the last 10 yr of adulthood. Higher scores indicate 
greater level of susceptibility to motion sickness. It has extensive 
normative data, enabling it to be converted into population 
percentiles. 
 Procedure 
 Th e survey covered  N  5 246 person-fl ights (193 men, 53 
women), ages (M  6 SD) 36.0  6 11.3 yr. Participants were 
invited to complete an anonymous questionnaire during the 
return leg of Airbus parabolic zero-G fl ights. Th e survey cov-
ered a 2-yr time period. Parabolic zero-G fl ights were per-
formed in a modifi ed Airbus A300 plane run by the Novespace 
company, fl ying from Bordeaux-Mérignac, France. Each fl ight 
had a pattern in which 31 parabolas were performed in blocks 
during the middle portion of the fl ight, which usually lasts 
around 2.5 h overall. Each parabola consisted of 20 s of 0 g 
sandwiched by 20 s of hypergravity periods of 1.5 – 1.8 g. 
 Statistical Analysis 
 Descriptives of the survey data were produced as means (SD) 
or percentages as appropriate. Initially the whole correlation 
matrix was examined to look for relationships between vari-
ables. Multivariate analyses were performed to predict motion 
sickness rating and vomiting. Multiple linear regression using 
the default enter method was used to produce a predictor model 
for the dependent variable of sickness rating, i.e., the maximum 
sickness rating experienced during the fl ight and to identify sig-
nifi cant predictors. Logistic regression was employed to pro-
duce a predictor model for the binary variable vomiting vs. no 
vomiting and to identify signifi cant predictors for vomiting. 
Analyses of subsets of the data were performed to further clar-
ify the sources of eff ects. Chi-square,  t -tests, or Fisher ’ s exact 
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tests were employed to further identify signifi cant eff ects where 
relevant. All signifi cance values that could be directional from 
the statistic employed were 2-tailed. Th e statistical package 
used was SPSS version 23. 
 RESULTS 
 General Characteristics 
 Since the survey was anonymous, it was not possible to be abso-
lutely defi nitive as to response rates. However, comparison of 
the numbers of completed questionnaires returned with the 
numbers of zero-G scientist fl iers or fl ight crews suggested that 
response rates to completing the questionnaire was approxi-
mately 95%. Most respondents reported completing the 
questionnaire immediately or within a few hours of the fl ight 
( Table I ). 
 Motion sickness was experienced by 33% and 12% vomited 
( Table I ). Motion sickness began for the majority during the 
middle or toward the end of the series of parabolas. Flight 
experience ( Table I ) of past zero-G fl ights averaged around 
eight fl ights and was rightward skewed by individuals who 
had fl own many times; the median experience of past zero-G 
fl ights was two. 
 Internal consistency of MSSQ was shown by MSA (child) 
correlating with MSB (adult), as was expected from the psy-
chometric properties of this instrument (r  5 0.66  P  , 0.0001). 
Participants were less susceptible than the general popula-
tion, with MSSQ percentile scores of 27.4  6 28.0 vs. a norm of 
50.  7  Th is fi nding of reduced inherent susceptibility was simi-
lar to that observed in a small earlier survey of zero-G fl iers  6  
and is shown in comparison with normative adult samples 
(see  Fig. 1 ). 
 Correlates and Predictors of Motion Sickness 
 Signifi cant correlates of motion sickness were as follows. Lower 
motion sickness ratings were associated with older age, greater 
prior zero-G fl ight experience, antimotion sickness medication 
with scopolamine, lower MSSQ scores, but not with gender or 
with anxiety (see  Table II ). In order to see if antimotion sick-
ness medication might act as a distorting factor, these relation-
ships were re-examined for the whole sample aft er subsetting 
into those who were medicated vs. unmedicated. Th e correla-
tions varied somewhat between these subsamples (see  Table II ), 
but it should be noted that the unmedicated group size was rela-
tively small when evaluating these associations within each 
subgroup. 
 It was noted that there was a signifi cant association between 
older age and greater previous zero-G fl ight experience (r  5 
0.42,  P  , 0.001). In order to attempt some separation of these 
eff ects on motion sickness, two types of subanalyses were per-
formed to isolate age eff ects on motion sickness and then to 
isolate fl ight experience eff ects on motion sickness. Th e sub-
sample of fi rst time fl iers had no prior zero-G fl ight experience 
by defi nition, but the relationship between older age and less 
motion sickness still remained robust and signifi cant (r  5 
 2 0.36,  P  , 0.001). Th en all fl iers were subset into younger ( , 
30 yr age) and older (  30 yr age) groups; this reduced the age 
with motion sickness correlations to nonsignifi cance (r  5 
 2 0.12,  P  5 n.s.; r  5  2 0.18,  P  5 ns; respectively). Interest-
ingly, the fl ight experience with motion sickness correlations 
remained signifi cant within both of these restricted age range 
subsamples (r  5  2 0.33,  P  , 0.01; r  5  2 0.28,  P  , 0.01; respec-
tively). Th ese subanalyses indicated that despite being corre-
lated with each other, both age and fl ight experience could act 
independently in their own right as signifi cant variables associ-
ated with motion sickness. 
 Motion sickness rating was predicted using multiple linear 
regression. Th e regression model [ F (4)  5 12.6,  P  , 0.0001, 
 Table I.  General Characteristics of Zero-G Fliers: Demographics, Motion 
Sickness and Other Variables as Means (SDs) or Percentages ( N  5 246). 
 VARIABLE MEAN (SD) OR % 
 Age (years) 36.0 (11.3) 
 Sex (Male %: Female %) 78% M: 22% F 
 Motion sickness rating (scale 1  5 OK to 6  5 
Vomiting)
2.0 (1.7) 
 Motion sickness: any symptoms (%) 33% 
 Vomited (%) 12% 
 Onset of motion sickness: beginning; middle; 
end of parabolas (%)
14% ; 45% ; 41% 
 Anxiety during fl ight (scale 0  5 none to 4  5 
extreme)
0.50 (0.67) 
 Flight experience (number of previous zero-G 
fl ights)
7.9 (19.1) 
 Antimotion sickness medication taken: Yes %; 
No %
87%; 13% 
 MSA childhood motion sickness susceptibility 
(subscale)
4.1 (5.0) 
 MSB adult motion sickness susceptibility 
(subscale)
2.7 (3.9) 
 MSSQ motion sickness susceptibility (total score) 6.8 (8.2) 
 MSSQ percentile (percentile of population norm) 27.4 (28.0) 
 Questionnaire completed: immediate;  , 1 h; 
1 – 3 h;  . 3 h; next day
30%; 26%; 23%; 8%; 13% 
  
 Fig. 1.  Motion Sickness Susceptibility Questionnaire (MSSQ) data are shown for 
normative samples and zero-G fl iers for the current study and in the year 2002.  6  
University student normative data  N  5 257; general adults normative data  N  5 
395; zero-G 2002 sample  N  5 23; current zero-G study  N  5 249; error bars are 
95% CIs. 
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adjusted R 2  5 0.17] showed that motion sickness rating could 
be signifi cantly predicted by the following variables (standard-
ized beta, signifi cance): fl ight experience (b  5  2 0.23,  P  , 
0.001); age (b  5  2 0.14,  P  , 0.05); MSSQ (b  5 0.16,  P  , 0.01); 
and antimotion sickness medication (b  5  2 0.24,  P  , 0.001). 
All other variables such as gender, anxiety, etc. were not signifi -
cant predictors. As a check for the robustness of the multiple 
linear regression model, half of the whole sample was randomly 
chosen for multiple linear regression. Th is generated a model 
which was then used to produce predicted motion sickness val-
ues in the other half of the sample. Th ere were no signifi cant 
observed vs. predicted diff erences; moreover, the strength of 
the relationship between observed and predicted motion sick-
ness ratings was signifi cant (r  5 0.41,  P  , 0.0001 2-tailed) and 
similar in magnitude to the strength of prediction using the 
whole sample. Th is provided support for the robustness of the 
predictive model. Logistic regression was then used to predict 
the risk of vomiting as a discrete event. Th e logistic regression 
model (omnibus  x 2  5 64.7, df  5 6,  P  , 0.0001; Nagelkerke 
R 2  5 0.34) gave 90% correct classifi cation for vomiting, and 
showed that vomiting was predicted by the following variables: 
less fl ight experience ( P  , 0.05); younger age ( P  , 0.05); and 
no use of antimotion sickness medication ( P  , 0.05). Although 
bivariate analysis showed that those who vomited had signifi -
cantly higher MSSQ scores ( P  , 0.05), MSSQ failed as a vom-
iting predictor when considered against fl ight experience, 
age, and medication in the logistic model. All other variables 
such as gender, anxiety, etc. were not signifi cant predictors of 
vomiting. 
 Th e following variables showed no useful relationships with 
motion sickness and were not analyzed further. Th ere was no 
relationship between motion sickness and when the question-
naires were completed (from immediately postfl ight through to 
the following day) (see  Table I ). Th ere was no signifi cant rela-
tionship between the onset time of symptoms of motion sick-
ness and the subsequent overall maximum motion sickness 
rating (either by correlation or by ANOVA). However, further 
analysis showed that those who eventually vomited were more 
likely to have developed motion sickness symptoms earlier at 
the beginning of the parabola series. Unfortunately, the num-
bers were too low to satisfy the minimum expected cell require-
ments of Chi-square, although this result was signifi cant at  P  , 
0.05 using Fisher ’ s exact test. Out of the 53 female fliers, 
7 reported that they were menstruating at the time of their zero-
G fl ight. Th ere was no obvious relationship with motion sick-
ness, but numbers were too low for meaningful statistical 
analysis. 
 Antimotion Sickness Medication 
 All respondents who took antimotion sickness medication who 
gave further details reported that they took scopolamine and 
did not report use of other types of medication despite 
prompts for other types in the free response box. Consequently, 
although not absolutely defi nitive due to the anonymous nature 
of the questionnaire, it is most likely that all or nearly all the 
antimotion sickness medications taken were scopolamine. Sco-
polamine was off ered as a routine voluntary option to all fl iers 
shortly prior to fl ight (s.c. injection 0.175 mg scopolamine, but 
reduced for any individual with low body mass; personal obser-
vations indicate that other fl iers may have brought and taken 
their own scopolamine medication as oral pills, taken shortly 
prior to fl ight). Th e mean motion sickness ratings for those who 
took scopolamine (1.81, SD 1.58) were less than half than those 
experienced by unmedicated fl iers (2.93, SD 2.16) and this dif-
ference was highly signifi cant ( t  5 3.5, df  5 242,  P  , 0.001 
2-tailed). Th e corresponding eff ect size of 0.6 for motion sick-
ness rating was  ‘ medium ’ by common convention, where eff ect 
size  ‘ d ‘  5 (mean1  – mean2)/(group SD). Th e incidence of vom-
iting in fl iers using scopolamine medication was reduced by 
almost half to a third compared with no medication ( x 2  5 6.8, 
df  5 1,  P  , 0.01) (see  Fig. 2 ). Th is can be stated as a risk ratio 
for vomiting  5 0.38, medication vs. no medication, i.e., reduced 
risk with medication. Th e equivalent risk ratio reduction with 
scopolamine vs. no medication for occurrence of any motion 
sickness  5 0.49. Possible confounding factors including age, 
sex, fl ight experience, or intrinsic motion sickness susceptibil-
ity (MSSQ) were considered. Confounding factors could not 
account for this scopolamine medication related reduction of 
motion sickness ratings or lower likelihood of vomiting. 
 Additional observations on eff ect sizes of antimotion sick-
ness medication are available for fl ights surveyed in the year 
2002 by the author,  6  where the medication issued was scopdex 
(oral combination of scopolamine 0.4 mg and dexamphetamine 
5 mg). Although the numbers were small, the motion sickness 
ratings were signifi cantly lower in the medicated vs. unmedi-
cated fl iers using the same motion rating scale as in the present 
 Table II.  Correlates of Motion Sickness Rating (Nonparametric Spearman Correlations) for All Zero-G Fliers and Subset by Those with Antimotion Sickness 
Medication or Not Medicated. 
 PREDICTOR VARIABLE FOR MOTION 
SICKNESS RATING
ALL ( N  5 246)
ANTIMOTION SICKNESS 
MEDICATED ( N  5 216)
NO MEDICATION 
( N  5 30) 
 r s  P r s  P r s  P 
 Age  2 0.28  , 0.001  2 0.20  , 0.01  2 0.60  , 0.001 
 Sex 0.03 n.s. 0.04 n.s. 0.00 n.s. 
 Flight Experience  2 0.34  , 0.001  2 0.27  , 0.001  2 0.81  , 0.001 
 Anxiety 0.09 n.s. 0.08 n.s. 0.18 n.s. 
 Antimotion medication  2 0.22  , 0.001 --- --- --- --- 
 MSSQ percentile 0.22  , 0.001 0.29  , 0.001 0.03 n.s. 
AEROSPACE MEDICINE AND HUMAN PERFORMANCE Vol. 88, No. 1 January 2017  5
MOTION SICKNESS & PARABOLIC FLIGHT — Golding  et al. 
survey (unmedicated  N  5 7, ratings m  5 4.43, SD 1.5; medi-
cated  N  5 16, ratings m  5 2.19, SD 2.0; signifi cant test diff er-
ence  t  5 2.7, df  5 21,  P  5 0.014 2-tailed). Th e eff ect size (d) 
for the reduction in sickness ratings with medication vs. no 
medication was d  5 1.28, i.e., somewhat larger for scopdex 
(d  5 1.28) than for scopolamine in the present survey, where 
d  5 0.6. 
 DISCUSSION 
 Th e aims of this study in zero-G fl iers were twofold: fi rstly, to 
assess the extent of the problem of motion sickness; and sec-
ondly, to identify predictors of motion sickness and possible 
modifying factors. Th e large size of the sample obtained being 
well over 200, the high response rate of around 95%, together 
with the anonymous nature of the survey to encourage truthful 
responses, all provided confi dence in the accuracy of our esti-
mate of the extent of motion sickness. In zero-G fl ights 33% of 
fl iers experienced some degree of motion sickness and 12% 
vomited. Th is is a lower incidence rate than for space sickness, 
where over 50% of astronauts have reported experiencing 
motion sickness in the fi rst 2 d of weightlessness before they 
adapt to the new environment.  1  Th e higher incidence rates in 
astronauts may refl ect their much greater exposure of days ( . 
48 h) in an altered force environment. By contrast, the 31 
parabolas in a single zero-G fl ight will only provide an accumu-
lated exposure of alternating 0 g and 1.5 – 1.8 g, totaling around 
31 min. 
 Fliers were intrinsically much less motion sickness suscep-
tible compared to the normal population as judged by a vali-
dated motion sickness susceptibility questionnaire (MSSQ).  7 , 15  
Fliers ’ MSSQ scores showed that their motion sickness suscep-
tibility averaged below the 30 th percentile of the general popula-
tion norms ( Fig. 1 ). Th is fi nding of reduced intrinsic motion 
sickness susceptibility was consistent with observations from a 
previous but much smaller survey of parabolic fl ights.  6  Th e 
most likely explanation for this is self-selection. Very suscepti-
ble individuals doubtless avoid such a provocative environment 
if they can. So rather than suggesting that less susceptible indi-
viduals are more attracted to undergoing parabolic fl ights, a 
better picture is that very highly susceptible individuals know 
that they are susceptible to motion sickness and consequently 
will tend to avoid this type of environment if they can. 
 Two of the most important predictors of increased risk of 
motion sickness were younger age and less prior experience of 
zero-G fl ights. However, these two variables were themselves 
signifi cantly interrelated, with older fl iers being more likely to 
have had greater prior parabolic fl ight experience. Th is is an 
unsurprising observation since older fl iers will have had a 
greater opportunity for additional zero-G fl ight experience. But 
this poses the problem of distinguishing between putative 
eff ects of age vs. prior parabolic fl ight exposure. By selecting 
subsamples to remove or reduce the eff ects of either age or 
fl ight experience, it was possible to demonstrate that both vari-
ables could exert their eff ects on motion sickness independently 
of each other. Th is was also the same picture revealed by multi-
variate analyses, where both age and fl ight experience remained 
signifi cant independent predictors of motion sickness when 
entered together in the analysis. Correlation does not prove 
causation, but it seems plausible that both these variables had 
a causal relationship with motion sickness. Th us, a general 
reduction in motion sickness susceptibility with age has been 
observed  15  and may be related to reduced sensitivity of ves-
tibular functioning,  3 , 17  and also perhaps reduced autonomic 
reactivity with age.  18  Equally, it is well known that repeated 
exposures to motion stimuli will cause habituation, which is 
the most plausible explanation for the reduced risk of motion 
sickness in those fl iers with greater previous zero-G fl ight 
experience. 
 MSSQ scores gave an estimate of intrinsic motion sickness 
susceptibility for individuals and this was a signifi cant predic-
tor for motion sickness. Higher MSSQ scores signifi cantly pre-
dicted greater motion sickness ratings during zero-G parabolic 
fl ight and likelihood of vomiting. Although highly statistically 
signifi cant, the actual magnitude of the strength of this associa-
tion was less than that observed in previous studies where 
MSSQ scores have been related with symptom scores and tol-
erance times to a variety of provocative motion stimuli and 
transport environments.  2 , 7  Th e most likely explanation for the 
weaker than expected relationship between MSSQ scores and 
observed motion sickness is restriction of range in the motion 
susceptibilities of the sample. As can be seen in  Fig. 1 , the range 
of MSSQ scores is very much lower than that expected in the 
general population. Th e lack of fl iers in the high MSSQ range 
will have greatly attenuated the possible degree of relationship. 
 Some variables such as anxiety or gender had little or no sig-
nifi cant association with motion sickness. Th e lack of any great 
association of anxiety with motion sickness here is perhaps 
unsurprising. Firstly, reported anxiety levels were very low 
and this will have had a range restriction eff ect. Secondly the 
  
 Fig. 2.  Motion sickness incidence for fl iers treated with the antimotion sickness 
drug scopolamine vs. untreated  ‘ no drug ’. Categories of sickness refer to the 
maximum sickness experienced. Each fl ier could only contribute to one cate-
gory which was the maximum experienced by that individual. 
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literature on the relationship between anxiety and motion sick-
ness has produced confl icting reports and suggests that such 
relationships may not be very strong or consistent.  15  Th e lack of 
any signifi cant relationship of motion sickness with gender is 
more surprising. It is oft en reported that females tend to be 
more susceptible.  10  However, to place this in context it should 
be noted that the eff ect of gender is much less than that of age 
on motion sickness susceptibility.  15  In space sickness there 
appears to be a lack of signifi cant diff erences in susceptibility 
between genders.  1  Th ere were relatively few women in the sam-
ple compared to men, which reduces the power to fi nd diff er-
ences. It is also possible that women who are more susceptible 
have self-selected themselves out; in other words, the selection 
eff ect observed for all fl iers may have been further enhanced in 
the women. All of these factors may have contributed to the 
observed lack of relationship between gender and motion sick-
ness in this survey. 
 One of the stronger predictors of motion sickness was usage 
of antimotion sickness medication, in all cases reported to be 
scopolamine. Motion sickness was signifi cantly lower in those 
who had taken scopolamine and this could not be explained by 
any possible confounding factors such as age, sex, prior fl ight 
experience, etc. Th is would suggest (but not prove) a causal 
eff ect since scopolamine is regarded as the best proven of all 
antimotion sickness drugs.  19  In terms of risk for any motion 
sickness the risk ratio reduction with scopolamine was 0.49 in 
zero-G fl iers, which is very similar to that proposed in the 
authoritative Cochrane Review  19  for the protective actions of 
scopolamine across a variety of motion environments of 0.48 
(95%CI 0.32 – 0.73). With regard to vomiting, the risk ratio 
reduction was 0.38 here, but the Cochrane Review  19  provides 
no equivalent estimates for reductions of risk of vomiting by 
scopolamine vs. no medication, nor for continuous measures of 
motion sickness. In the present study, the value of the reduction 
in vomiting risk is particularly useful given the relative lack of 
data on this metric for protection by scopolamine. Concerning 
continuous rating measures, the eff ect size (d) here for scopol-
amine was a reduction of 0.6, which is broadly similar to the 0.5 
observed in the laboratory using tolerance of cross-coupled 
motion to levels of moderate nausea.  9  All of these comparisons 
provide a practical estimate for the degree of protection that 
may be provided by scopolamine against motion sickness in the 
real environment of zero-G fl ight. Th is may be summarized as a 
signifi cant, but far from total protection by scopolamine against 
motion sickness. 
 Th is survey was anonymous, which is both a strength and a 
possible limitation. Anonymity encourages truthful responses, 
but had the limitation that we could not identify and select indi-
viduals who may have fl own for the fi rst time then for all three 
successive fl ights over a 1-wk time period (the normal para-
bolic fl ight  ‘ campaign ’ ). Th e identifi cation of the data for such 
individuals would have been of interest in terms of investigating 
the dynamics of possible habituation to successive parabolic 
fl ights. Th e questionnaire was kept deliberately short to encour-
age a high response rate, which was successfully achieved. But 
this inevitably limited some areas of questioning; for example, 
we kept the symptom scoring short and simple, which excluded 
extensive questions on detailed symptoms such as drowsiness 
or  ‘ sopite. ’  22  Equally detailed questioning of what the fl ier was 
doing in term of physically moving around, body postures 
adopted during zero and hypergravity, head movements, etc. 
would have been of interest, but would have made the question-
naire longer again. Finally, although this study provided exten-
sive data on motion sickness incidence and on the intrinsic 
characteristics of fl iers, including motion sickness susceptibil-
ity, the individual predictors for risk of motion sickness left  
much unexplained variance, despite being highly signifi cant. 
 In conclusion, motion sickness aff ected one-third of zero-G 
fl iers to some extent. Of the zero-G fl iers, 1 out of 10 vomited. 
Fliers were intrinsically less motion sickness susceptible com-
pared to the normal population, perhaps because more motion 
sickness susceptible individuals try to avoid such a provocative 
environment if they can. Since this was a survey, the follow-
ing predictive factors cannot be proven causal, although they 
are plausible. Th e main risk factors for motion sickness were 
younger age and higher MSSQ scores. Protective factors included 
greater prior zero-G fl ight experience, probably refl ecting habit-
uation and medication prior to the fl ight with the antimotion 
sickness drug scopolamine. 
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